| Reduce Risk for Crohn's Disease Patients (NCT02852694) | PIBD-Net | 2017-02-28 |
| VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease (NCT03257345) | University Hospital Southampton NHS Foundation Trust | 2017-02-03 |
| Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease (NCT03000101) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2017-01-19 |
| Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (NCT02862132) | Shaare Zedek Medical Center | 2017-01-01 |
| The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease (NCT03056664) | Sixth Affiliated Hospital, Sun Yat-sen University | 2017-01-01 |
| Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease (NCT03698500) | University Hospital Muenster | 2017-01-01 |
| The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission (NCT02930564) | Wolfson Medical Center | 2017-01-01 |
| Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA ) (NCT02896985) | AbbVie | 2016-12-16 |
| A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease (NCT02891226) | Eli Lilly and Company | 2016-12-14 |
| A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease (NCT02976129) | VHsquared Ltd. | 2016-12-01 |
| The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's Disease (NCT02231814) | Prof. Arie Levine | 2016-12-01 |
| Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease (NCT02914561) | Lakefront Biotherapeutics NV | 2016-10-31 |
| A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis (NCT02883452) | Celltrion | 2016-09-29 |
| Relationship Between Prophylactic Drainage and Postoperative Complications (PPOI) in Crohn's Patients After Surgery (NCT03815851) | Jinling Hospital, China | 2016-09-06 |
| The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases (NCT02858557) | Tel-Aviv Sourasky Medical Center | 2016-09-01 |
| MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients (NCT02882841) | Enterome | 2016-09-01 |
| Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease (NCT02630966) | Takeda | 2016-08-10 |
| Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (NCT02765256) | University of Pennsylvania | 2016-08-01 |
| PillCam SBC System Functionality in Established and Suspected IBD Patients (NCT02742714) | Medtronic - MITG | 2016-07-01 |
| Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy (NCT02793778) | Prometheus Laboratories | 2016-07-01 |
| Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease (NCT02846961) | Kyungpook National University Hospital | 2016-07-01 |
| Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease (NCT02825316) | michal roll | 2016-07-01 |
| Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease (NCT02801240) | National University of Natural Medicine | 2016-06-01 |
| COmparison of MicroBiota AccordIng to Age in Crohn's Disease (COMeBACk) (NCT02839317) | University Hospital, Lille | 2016-05-09 |
| Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) (NCT02538341) | University of Alabama at Birmingham | 2016-05-01 |
| Laparoscopy Combined With Enhanced Recovery Pathway (NCT02777034) | Sir Run Run Shaw Hospital | 2016-05-01 |
| Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease (NCT02716454) | Ondrej Ryska | 2016-05-01 |
| Osteopathy Non-manipulative in Patients With Crohn's Disease. (NCT02763293) | University of Valencia | 2016-05-01 |
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec (NCT02789800) | Université de Sherbrooke | 2016-04-22 |
| A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease (NCT02620046) | Takeda | 2016-04-15 |
| A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD) (NCT02749630) | Genentech, Inc. | 2016-04-11 |
| Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) (NCT02750800) | AbbVie | 2016-04-07 |
| Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease (NCT02685683) | Celgene | 2016-04-04 |
| The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction (NCT02488005) | Icahn School of Medicine at Mount Sinai | 2016-04-01 |
| Imaging Biomarkers in Crohn's Associated Spondyloarthritis (NCT02709694) | Hospital for Special Surgery, New York | 2016-04-01 |
| Body Composition in Children With Inflammatory Bowel Disease (NCT02745457) | Schneider Children's Medical Center, Israel | 2016-04-01 |
| Corticosteroids With Vedolizumab in Crohn's Disease (NCT02324699) | Icahn School of Medicine at Mount Sinai | 2016-04-01 |
| Predictive Model of Clinical Outcomes Using Web-based Self-reporting Symptom Diary for Crohn's Disease (NCT02760836) | Kyungpook National University Hospital | 2016-04-01 |
| The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer (NCT02769494) | Xijing Hospital of Digestive Diseases | 2016-03-01 |
| Improving the Quality of Care for Adults With Inflammatory Bowel Disease (NCT02791854) | Dartmouth-Hitchcock Medical Center | 2016-02-26 |
| The Vitamin D in Pediatric Crohn's Disease (NCT02186275) | St. Justine's Hospital | 2016-02-01 |
| To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease (NCT02649075) | Entera Health, Inc | 2016-02-01 |
| Patient-Centred Innovations for Persons With Multimorbidity - Ontario (NCT02742597) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-12 |
| Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease (NCT02574637) | AstraZeneca | 2016-01-05 |
| Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) (NCT02611817) | Takeda | 2016-01-04 |
| Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD (NCT02680756) | Shield Therapeutics | 2016-01-01 |
| The Efficiency of MSC in Refractory Crohn's Disease (NCT02532738) | Sixth Affiliated Hospital, Sun Yat-sen University | 2016-01-01 |
| A Pilot Study of FFP104 in Subjects With Crohn's Disease (NCT02465944) | Fast Forward Pharmaceuticals | 2016-01-01 |
| OTIS Vedolizumab Pregnancy Exposure Registry (NCT02678052) | Takeda | 2015-12-01 |
| Fecal Microbiome Transplant (NCT02636517) | Judith Kelsen | 2015-12-01 |
| The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease (NCT02578576) | Jinling Hospital, China | 2015-12-01 |
| Study of Bacteroides Thetaiotaomicron in Young People Aged 16 to 18 Years With Stable Crohn's Disease (NCT02704728) | 4D pharma plc | 2015-12-01 |
| Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis (NCT02549976) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2015-12-01 |
| A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease (NCT02580617) | Anterogen Co., Ltd. | 2015-11-09 |
| Nutritional Therapy Study in Pediatric Crohn's Disease (NCT02610101) | Seattle Children's Hospital | 2015-11-01 |
| Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) (NCT02926300) | Kang Stem Biotech Co., Ltd. | 2015-11-01 |
| Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment (NCT02622763) | Fundacion Clinic per a la Recerca Biomédica | 2015-11-01 |
| Does Clinical Response Correlate With Serum Certolizumab Levels? (NCT02597829) | Shafran Gastroenterology Center | 2015-11-01 |
| European Novel Motorized Spiral Endoscopy Trial (NCT02965209) | Evangelisches Krankenhaus Düsseldorf | 2015-11-01 |
| Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) (NCT02622139) | University of Erlangen-Nürnberg Medical School | 2015-11-01 |
| Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease (NCT02531113) | Celgene | 2015-10-09 |
| A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy (NCT02177071) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2015-10-09 |
| Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital (NCT02998398) | Assistance Publique - Hôpitaux de Paris | 2015-10-01 |
| Bologna IBD Markers (NCT02580864) | Société des Produits Nestlé (SPN) | 2015-10-01 |
| IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study (NCT02847884) | University of Alberta | 2015-10-01 |
| A First Time in Human Study in Healthy Volunteers and Patients (NCT03010787) | VHsquared Ltd. | 2015-09-01 |
| Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study (NCT02542917) | King's College Hospital NHS Trust | 2015-09-01 |
| Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT) (NCT02417974) | Boston Medical Center | 2015-09-01 |
| Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease (NCT02499783) | AbbVie | 2015-08-17 |
| A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques (NCT02538679) | Cedars-Sinai Medical Center | 2015-08-07 |
| "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" (NCT02452151) | Onze Lieve Vrouwe Gasthuis | 2015-08-01 |
| Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease (NCT02193750) | University of British Columbia | 2015-08-01 |
| Extension Study of MT-1303 in Subjects With Crohn's Disease (NCT02389790) | Tanabe Pharma Corporation | 2015-08-01 |
| Phenomics in Autoimmune and Inflammatory Diseases (NCT02466217) | Assistance Publique - Hôpitaux de Paris | 2015-07-29 |
| An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) (NCT02451839) | AbbVie | 2015-07-06 |
| Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation (NCT02269358) | Prof. Arie Levine | 2015-07-01 |
| The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness (NCT02423512) | Icahn School of Medicine at Mount Sinai | 2015-06-01 |
| Reduced Appetite in Crohn's Disease: The Role of the Brain in the Control of Food Intake (NCT02772458) | University of Nottingham | 2015-06-01 |
| The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease (NCT02481687) | University of Medicine and Pharmacy Craiova | 2015-06-01 |
| Medication Adherence in Patients With Inflammatory Bowel Disease (IBD) (NCT02620514) | Emory University | 2015-06-01 |
| Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator (NCT02413047) | Indiana University | 2015-05-01 |
| Threonine Requirement in IBD Adults and Healthy Adult Controls (NCT02423460) | Société des Produits Nestlé (SPN) | 2015-05-01 |
| Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial (NCT02256462) | Schneider Children's Medical Center, Israel | 2015-05-01 |
| SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins (NCT02383953) | St Stephens Aids Trust | 2015-05-01 |
| Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease (NCT02405442) | Gilead Sciences | 2015-04-30 |
| Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease (NCT02539368) | Pfizer | 2015-04-22 |
| Top-down Infliximab Study in Kids With Crohn's Disease (NCT02517684) | Erasmus Medical Center | 2015-04-01 |
| Eating Behaviour in Crohn's Disease (NCT02379117) | University of Nottingham | 2015-04-01 |
| Acupuncture Treatment for Active Crohn's Disease (NCT02559037) | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 2015-04-01 |
| Trial of High Dose Vitamin D in Patient's With Crohn's Disease (NCT02208310) | University of Michigan | 2015-04-01 |
| Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease (NCT02425111) | Takeda | 2015-03-30 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy (NCT02365649) | AbbVie | 2015-03-17 |
| Corticosteroid Dosage for Crohn's Disease Flare (NCT02392286) | Yale University | 2015-03-01 |
| High-dose Cyclophosphamide for Severe Refractory Crohn Disease (NCT01836289) | Johns Hopkins University | 2015-03-01 |
| Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease (NCT02378688) | Tanabe Pharma Corporation | 2015-03-01 |
| Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin (NCT02624414) | Melbourne Health | 2015-02-06 |
| RED-FLAGS Index Validation in Crohn's Disease Patients (NCT02940054) | Istituto Clinico Humanitas | 2015-02-01 |
| Contrast-Enhanced Ultrasound in Human Crohn's Disease (NCT02061163) | University of Michigan | 2015-02-01 |
| Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life (NCT02322307) | Icahn School of Medicine at Mount Sinai | 2015-02-01 |
| Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease (NCT02335281) | Yanling Wei | 2015-01-01 |